New Jersey biotech Edge Therapeutics just raised $72.5 million from two new financing rounds, with aims to advance its drug delivery system for brain hemorrhaging and other acute neurological conditions into Phase 3. Edge has two novel product candidates under development – one for subarachnoid hemorrhage, and the other as a prophylactic treatment for chronic subdural hematoma […]
Angel investor tax credits are one way states are trying to stimulate investment in seed and early stage biotechnology companies. The idea is that it will help companies grow in the state and produce jobs and ultimately attract even more business to the state. Biopharmaceutical company Edge Therapeutics is the first biotechnology company to benefit […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.